Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Dow
Baxter
AstraZeneca
Boehringer Ingelheim

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

ULTRAVATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Ultravate patents expire, and what generic alternatives are available?

Ultravate is a drug marketed by Sun Pharm Inds Inc and Sun Pharm Industries and is included in three NDAs. There is one patent protecting this drug.

This drug has twenty patent family members in seventeen countries.

The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.

Drug patent expirations by year for ULTRAVATE
Drug Prices for ULTRAVATE

See drug prices for ULTRAVATE

Recent Clinical Trials for ULTRAVATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valeant Pharmaceuticals International, Inc.Phase 2
Valeant Pharmaceuticals International, Inc.Phase 1
Therapeutics, Inc.Phase 2

See all ULTRAVATE clinical trials

Recent Litigation for ULTRAVATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Sun Pharmaceutical Industries, Inc. v. Perrigo Company2018-05-10
Sun Pharmaceutical Industries, Inc. v. Perrigo Company2018-05-09
HOLLANDER v. RANBAXY LABORATORIES INC.2010-02-23

See all ULTRAVATE litigation

Pharmacology for ULTRAVATE
Synonyms for ULTRAVATE
(1R,8S,13S,14R)-14-(2-chloroacetyl)-1,8-difluoro-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-14-yl propanoate
(6|A,11|A,16|A)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
(6|A,11|A,16|A)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; Miracorten; Ulobetasol propionate; Ultravate
(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
6 alpha-fluoroclobetasol 17-propionate
6-fluoroclobetasol 17-propionate
66852-54-8
852H548
91A0K1TY3Z
AB01566925_01
AB2000750
AC1L2JJ6
AC1OCF43
AKOS025310143
AN-14228
API0002882
AS-14150
BDSYKGHYMJNPAB-LICBFIPMSA-N
BMY 30056
BMY-30056
C25H31ClF2O5
CAS-66852-54-8
CGP 14 458
CGP 14458
CGP-14,458
CGP-14458
CHEBI:135782
CHEMBL1200908
CHEMBL1876307
CS-4305
CTK8G0126
D04409
DSSTox_CID_26636
DSSTox_GSID_46636
DSSTox_RID_81782
DTXSID6046636
Halobetasol (propionate)
HALOBETASOL PROPIONATE
Halobetasol propionate (USAN)
Halobetasol propionate [USAN:USP]
Halobetasol propionate [USAN]
Halobetasolpropionate
HY-B0878
K097
LS-118431
Miracorten
MolPort-006-167-587
MolPort-023-278-129
NCGC00167451-01
NCGC00373230-02
Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6alpha,11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-,(6-alpha,11-beta,16-beta)-
s4089
SC-18329
SCHEMBL1650038
SCHEMBL33858
SR-01000942239
SR-01000942239-1
Tox21_112455
Ulobetasol (Halobetasol)Propionate
Ulobetasol cream
Ulobetasol propionate
Ultravate (TN)
UNII-91A0K1TY3Z
ZINC3920028
Paragraph IV (Patent) Challenges for ULTRAVATE
Tradename Dosage Ingredient NDA Submissiondate
ULTRAVATE LOTION;TOPICAL halobetasol propionate 208183 2018-01-24

US Patents and Regulatory Information for ULTRAVATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate CREAM;TOPICAL 019967-001 Dec 27, 1990 AB RX Yes No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183-001 Nov 6, 2015 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate OINTMENT;TOPICAL 019968-001 Dec 17, 1990 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ULTRAVATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate CREAM;TOPICAL 019967-001 Dec 27, 1990   Start Trial   Start Trial
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate OINTMENT;TOPICAL 019968-001 Dec 17, 1990   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
Colorcon
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.